Isradipine Extended-Release Tabs Rx
Generic Name and Formulations:
Isradipine 5mg, 10mg; ext-rel tabs.
Indications for Isradipine Extended-Release Tabs:
Do not crush or chew. Initially 5mg once daily, alone or with a thiazide diuretic. May increase by 5mg/day at 2–4 week intervals; max 20mg/day.
CHF. GI narrowing (CR). Pregnancy (Cat.C). Nursing mothers: not recommended.
β-blockers may potentiate heart failure. Severe hypotension possible with fentanyl.
Calcium channel blocker (CCB) (dihydropyridine).
Dizziness, edema, palpitations, fatigue, flushing, dyspnea, GI upset, tachycardia, rash, pollakiuria, weakness, headache.
Formerly known under the brand name Dynacirc CR.
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine